This study found Notch1, Notch2, and Notch4 to be involved in stromal-dependent CLL resistance to fludarabine and cyclophosphamide chemotherapy, with mesenchymal stem cells dramatically increasing tumor cell survival. This evidence concerns the gene NOTCH2 and B-cell chronic lymphocytic leukemia.